CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Global Biotecnologia has been recognized by Life Sciences Review Magazine as the exclusive recipient of “Top 10 Biotech Companies in Latin America - 2022,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the Life Sciences Review research and editorial team based on insights from an interview with , .

Global Biotecnologia
Innovation. Sustainability. Life.

Global Biotecnologia

Victor Weber, CFO, Global BiotecnologiaVictor Weber, CFO
For decades, best practices in agriculture were developed based on the conditions found in temperate regions. But countries like Brazil realized that these models were not suited to their tropical climate, seasons, and land, driving the nation to invest more in biotechnology and agricultural innovation. Today, Brazil has become one of the leading producers of biotech crops. The country has gone from being a basic food importer to one of the world’s largest food producers and exporters.

The constant demand for production without affecting the environment, however, remains a challenge for this sector today. There is a growing requirement to bridge the gap between sustainability and innovation.

Understanding this need in the market is Global Biotecnologia—a 100 percent Brazilian biotechnology company and a member of the Sustainable Community Development—that works on the principles of innovation, sustainability, and life.

TCP: The Game Changer

Global Biotecnologia has developed the production process that encompasses what Probiotic Consortium Technology or TCP is all about: the production of living ecosystems. The company’s engineered microbiomes enable rural producers to lower production costs, increase production, and ultimately, increase their income.

TCP is a process of cultivation and development of ecosystems; projected microbiomes. Different populations of microorganisms are added with specific stabilization times for each process to create social groups. This, with physical and chemical patterns for each phase, results in probiotic blends, ecosystems, or even projected microbiomes.

These microbiomes produce organic acids, enzymes, amino acids, sugars, vitamins, and natural antibiotics, the well-known and overvalued metabolites or post-biotics, and interact with native, beneficial microorganisms when they come in contact with organic matter.

Products created from designed microbiomes survive in hostile environments and have efficiency and effectiveness in environments ranging from 5° to 50°C and pH from 2 to 14, with a shelf life of up to 3 years.

“With TCP, we can create value and make a difference wherever we are and in everything we do. We have the chance to inspire people and bring health to the soil, plant, water, air, and, above all, to people,” says Miro Alvernaz, the CEO of Global Biotecnologia.

Technological Innovations for Agribusiness

Global Biotecnologia operates in more than 30 countries, helping producers to reduce costs, increase production, and benefit the environment. Currently, it has more than ten confidentiality terms with national and multinational companies that want to understand and include TCP in their portfolio. For example, the use of ionophores in chickens will soon be banned in Brazil. Global Biotecnologia is the only company with the ability to replace them without any productivity loss.

  • We are carrying out multiple experiments and scientific studies with top universities across Brazil and abroad to take our technological innovations to the next level


Similarly, the Ukraine war has increased the cost of growing due to higher fertilizer prices. Global Biotecnologia offers an all-in-one commercial product that brings greater productivity while controlling nematodes, fungi, fixing nitrogen, solubilizing phosphor, and potassium. This drastically reduces the need to import fertilizers, ultimately reducing crop costs.

“We are carrying out multiple experiments and scientific studies with top universities across Brazil and abroad to take our technological innovations to the next level,” says Alvernaz.
Global Biotecnologia’s products are 100 percent natural and have certification of compliance with European, American, and Asian markets. This has been possible due to the scientific studies and field tests that the company carries out in commercial areas with the main institutions in Brazil, and with renowned experts in Brazilian agribusiness.

A Testament to Excellence

Over the years, Global Biotecnologia has worked on various cases with their natural products. This includes the elimination of salmonella and ammonia in broilers—a problem for both production and export. But one example that attests to the company’s dedication to innovation and sustainability is the case of a swine farm in the state of Paraná that was suffering due to coccidiosis that caused the death of piglets.

The client used disinfectants and huge doses of antibiotics and anticoccidials without optimum outcomes. Working with the client, Global Biotecnologia removed the disinfectants, detergents, antibiotics, and anticoccidials, and implemented an integrated solution in the production environment and in the nutrition of sows and piglets during pregnancy and farrowing.

The company ensured cost reduction for the farm and zero piglet mortality while increasing piglet weight by more than 500g per animal.

Another case is shrimp farming. A few years ago, Global Biotecnologia went to some farms that had problems with Vibrio—a genus of gram-negative bacteria—and started the production process with TCP. It bolstered the shrimp’s immune system by controlling water levels. This allowed the company to defeat Vibrio and increase productivity by 80 percent. And in the case of white spot syndrome (WSS)—a viral infection of penaeid shrimp— which devastated up to 100 percent of production in a matter of days, Global Biotecnologia managed to reduce the loss to an average of 30 percent.

Production of Living Ecosystems

Currently, Global Biotecnologia is focused on creating an employee base that aligns with the company’s mission and vision. Together with like-minded people, it wants to make a long-lasting difference in the market and people’s lives.

With TCP, we can create value and make a difference wherever we are and in everything we do. We have the chance to inspire people and bring health to the soil, plant, water, air, and, above all, to people

“All our solutions are, and will, bringing health to people—in body, mind, and spirit. Our biggest competitive advantage is the truth that you see in each of our employees,” says Alvernaz.
There is no denying that microbiome-based technologies will change the world of agriculture. And Brazil is leading the revolution with Global Biotecnologia. The South American giant has a great chance of being an example of sustainability, while breaking production records in soy, corn, sugarcane, and animal protein. In other words, Global Biotecnologia and the industry are facing a Brazilian biological revolution, and the company’s TCP is the great protagonist.

Top 10 Biotech Companies in Latin America - 2022
Current Issue

Company : Global Biotecnologia

Management
Victor Weber, CFO
Miro Alvernaz, CEO

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/global-biotecnologia